Q3 2025 Organigram Global Inc Earnings Call Transcript
Key Points
- Organigram Global Inc (OGI) reported record-breaking gross and net revenue for Q3 fiscal 2025, driven by strong domestic market leadership and international expansion.
- The company maintained its position as the number one licensed producer in Canada's recreational cannabis market with an 11.6% market share.
- Organigram's Shred brand achieved a 69% repurchase rate across all categories, indicating strong customer loyalty.
- International revenue grew by 208% year over year, with significant contributions from exports to Germany, Australia, and the UK.
- Operational improvements, including LED lighting upgrades and nutrient optimization, increased annual capacity by over 14,000 kg, enhancing production efficiency.
- The integration of Motif into Organigram's ERP system caused temporary disruptions, leading to a 30 basis point decline in overall market share in Q3.
- Adjusted gross margin rate decreased by approximately 200 basis points year over year, primarily due to temporary drag from Motif's integration.
- Net loss for the quarter was $6.3 million, compared to net income of $2.8 million in the prior year period, influenced by non-cash changes in derivative liabilities.
- The company is still awaiting EU GMP certification, which has delayed potential margin improvements from international sales.
- Operating expenses increased by 8.5% to $28.2 million, representing approximately 40% of net revenue, which may impact profitability if not managed effectively.
Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organogram Global third quarter fiscal 2025 earnings conference call.
After the speaker's remarks, there will be a question and answer session. We ask that you please limit yourself to one question and one follow up question. You may reach you if you have any further questions.
Thank you, Max Max Schwartz. You may begin.
Thank you, Krista, and good morning and thanks for joining us today. As a reminder, this conference call is being recorded and the recording will be available on Organogram's website 24 hours after today's call.
(Operator Instructions)
Further reference will be made to certain non-IFRS measures during this call, including adjusted EBITDA, adjusted gross margin percentage, and free cash flow.
These measures do not have any standardized meaning under IFRS and are intended to provide additional information and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
